Calon Cardio Technologies Ltd.

Calon Cardio-Technology (Calon) was established in 2007.  It is a small, pre-revenue company that specialises in the development of blood pumps for the treatment of chronic and acute heart failure. Its goal is to make a low-cost, minimally-invasive pump the number one choice for heart failure treatment, world-wide.  Thus far, it has developed a haemolysis free pump and is about to conduct the first of many acute in-vivo trials.  In just four short years, and despite a recession, Calon has not only raised interest but also investment from seed, grant and investor funding.  To date the figure raised is 2.2 million, made up of grants from TSB and Welsh Government and private investment from Longbow Capital and Finance Wales.